Venous Thrombosis Following Diagnostic Transvenous Catheterization by Percutaneous Catheter Insertion: An Evaluation of Desmopressin as a Thromboprophylactic Agent

Summary

The preventive effect of desmopressin with respect to catheter induced thrombosis was studied in a randomized double-blind trial, consisting of 30 patients undergoing percutaneous transcubital right heart catheterization. Phlebography of the catheterized arm was performed after five days. The frequency of postcatheterization thrombosis was reduced by 33 per cent, from 86 per cent in the treatment group to 53 per cent in the control group (0.1 <p <0.2). This effect was restricted to minor thrombi, whereas major thrombosis could not be prevented.

Patient materials such as that of the present study, may become useful in preliminary investigations of thromboprophylactic agents.

Keywords

Transvenous catheterization - Desmopressin - Fibrinolysis - Venous thrombosis

• References

• 1 Nolewajka AJ, Goddard MD, Brown TC. Temporary transvenous pacing and femoral vein thrombosis. Circulation 1980; 62: 646-650
• 2 Pandian NG, Kosowsky BD, Gurewich V. Transfemoral temporary pacing and deep vein thrombosis. Am Heart J 1980; 100: 847-851
• 3 Walters MB, Stanger HA D, Rotem CE. Complications with percutaneous central venous catheters. Jama 1972; 220: 1455-1457
• 4 Brismar B, Hårdstedt C, Jacobson S. Diagnosis of thrombosis by catheter phlebography after prolonged central venous catheterization. Ann Surg 1981; 194: 779-783
• 5 Libsack CV, Kollmeyer KR. Role of catheter surface morphology on intravascular thrombosis of plastic catheters. J Biomed Mater Res 1979; 13: 459-466
• 6 Hoar PF, Stone JG, Wicks AE, Edie RN, Scholes JV. Thrombogenesis associated with Swan-Ganz catheters. Anesthesiology 1978; 48: 445-447
• 7 Matsuo O, Rijken DC, Collen D. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro. Thromb Haemostas 1981; 45: 225-229
• 8 Mannucci PM, Åberg M, Nilsson IM, Robertson B. Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol 1975; 30: 81-93
• 9 Nilsson IM, Holmberg L, Åberg M, Vilhardt H. The release of plasminogen activator and factor VIII after injection of DDAVP in healthy volunteers and in patients with von Willebrand’s disease. Scand J Haematol 1980; 24: 351-359
• 10 Brommer EJ, Barrett-Bergshoeff MM, Allen RA, Schicht I, Bertina RM, Schalekamp MA. The use of desmopressin acetate (DDAVP) as a test of the fibrinolytic capacity of patients - analysis of responders and nonresponders. Thromb Haemostas 1982; 48: 156-161
• 11 Nordby E, Amesen H, Andersen P, Godal HC. The euglobulin clot lysis time, a rapid and sensitive method for the assay of fibrinolytic activity after venous stasis. Scand J Haematol 1980; 25: 407-411
• 12 Hjermann I, Velve ByreK, Holme I. Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo study group of a randomized trial in healthy men. Lancet 1981; 2: 1303-1310
• 13 Egberg N, Ekestrøm S. Effect of DDAVP injection on platelet adhesiveness and fibrinopeptide A in patients with angina pectoris. Thromb Haemostas 1983; 50: 207 (Abstr.)